Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $1.24M in Stock for its fiscal quarter ending in December of 2022. Data for Adamis Pharmaceuticals | ADMP - Stock including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $7.55M in Current Assets for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Current Assets including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $12.95M in Current Liabilities for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Current Liabilities including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $-6427680 in Operating Profit for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Operating Profit including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $1.85M in Debt for its fiscal quarter ending in March of 2022. Data for Adamis Pharmaceuticals | ADMP - Debt including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $1.79M in Cost of Sales for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Cost Of Sales including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $9.78M in Trade Creditors for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Trade Creditors including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $-6318210 in EBITDA for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Ebitda including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported 11 in Employees for its fiscal year ending in December of 2022. Data for Adamis Pharmaceuticals | ADMP - Employees Total Number including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $-0.06 in EPS Earnings Per Share for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - EPS Earnings Per Share including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $-335070 in Gross Profit on Sales for its fiscal quarter ending in March of 2023. Data for Adamis Pharmaceuticals | ADMP - Gross Profit On Sales including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals reported $-8335000 in Pre-Tax Profit for its fiscal quarter ending in June of 2022. Data for Adamis Pharmaceuticals | ADMP - Pre Tax Profit including historical, tables and charts were last updated by Trading Economics this last March in 2025.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Adamis Pharmaceuticals stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.